Takahisa Gono

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region
  Takahisa Gono, Vidya Sadanand Limaye, Latika Gupta +10 more
  Rheumatology 2026 DOI: 10.1093/rheumatology/keag306
  +Save
• Critical ischemia of multiple organ systems in a patient with systemic lupus erythematosus complicated by catastrophic antiphospholipid syndrome: Potential pathogenetic role of non-inhibitory anti-ADAMTS13 autoantibodies
  Modern Rheumatology Case Reports 2026 DOI: 10.1093/mrcr/rxag053
  +Save
• Prevalence and screening of interstitial lung disease in rheumatoid arthritis
  Rheumatology Advances in Practice 2026 DOI: 10.1093/rap/rkag062
  +Save
• Performance and potential impact of the IMACS cancer screening guideline in myositis: analysis in a myositis referral centre
  Rheumatology Advances in Practice 2026 DOI: 10.1093/rap/rkag027
  +Save
• Rapidly progressive fibrinopurulent pleural empyema with systemic juvenile idiopathic arthritis during treatment with tocilizumab
  Rheumatology Advances in Practice 2026 DOI: 10.1093/rap/rkag001
  +Save
• Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis
  Takahisa Gono, Albert Gil‐Vila, Albert Selva-O’Callaghan

  +23 more

  • Annet van Royen‐Kerkhof
  • Anett Vincze
  • Christopher A. Mecoli
  • Diana Gómez‐Martín
  • Dörte Hamann
  • +18 more
  Seminars in Arthritis and Rheumatism 2025 DOI: 10.1016/j.semarthrit.2025.152858
  +Save
• Seroconversion of Rheumatoid Factor Prior to the Onset of Rheumatoid Arthritis in Patients With Interstitial Lung Disease: A Single‐Center Retrospective Case Series
  International Journal of Rheumatic Diseases 2024 DOI: 10.1111/1756-185X.70017
  +Save
• Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis
  Rheumatology Advances in Practice 2024 DOI: 10.1093/rap/rkae049
  +Save
• Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
  Diagnostics 2023 DOI: 10.3390/diagnostics13243621
  +Save
• The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review
  Current Rheumatology Reports 2023 DOI: 10.1007/s11926-023-01120-x
  +Save
• Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments
  RMD Open 2023 DOI: 10.1136/rmdopen-2023-003268
  +Save
• New paradigm in the treatment of myositis-associated interstitial lung disease
  Expert Review of Respiratory Medicine 2023 DOI: 10.1080/17476348.2023.2215433
  +Save
• Immune Cell Signatures to Stratify Patients With Systemic Autoimmune Diseases: A Step Toward Individualized Medicine?
  Arthritis & Rheumatology 2022 DOI: 10.1002/art.42263
  +Save
• Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease
  Arthritis & Rheumatology 2021 DOI: 10.1002/art.41566
  +Save
• Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
  PLOS ONE 2020 DOI: 10.1371/journal.pone.0234523
  +Save